Item 8.01. Other Events

On January 8, 2021, PAVmed Inc. (the "Company") closed on the sale of 6,000,000 shares of its common stock, pursuant to its previously announced offering of shares of common stock at a price of $2.24 per share (the "Offering").

Maxim Group LLC acted as the sole placement agent in connection with the Offering.

The Offering was made pursuant to the Company's existing shelf registration statement on Form S-3 (Registration No. 333-248709), which was filed with the Securities and Exchange Commission ("SEC") on September 10, 2020 and declared effective by the SEC on September 17, 2020, and is described in more detail in a prospectus supplement dated January 5, 2021 and accompanying base prospectus dated September 17, 2020 filed with the SEC.

On January 8, 2021, the Company issued a press release announcing that it had closing the Offering. The press release is attached to this Current Report as Exhibit 99.1 and is incorporated herein by reference.

© Edgar Online, source Glimpses